9 results on '"Luis Huertas, A. L."'
Search Results
2. Combined exercise intervention in a mouse model of high-risk neuroblastoma: effects on physical, immune, tumor and clinical outcomes.
- Author
-
Rincón-Castanedo, Cecilia, Martín-Ruiz, Asunción, Zazo, Sandra, Luis Huertas, Ana L., Valenzuela, Pedro L., Morán, María, Fleck, Steven J., Santos-Lozano, Alejandro, Ramírez, Manuel, Rojo, Federico, Lucia, Alejandro, González-Murillo, África, and Fiuza-Luces, Carmen
- Subjects
NEUROBLASTOMA ,EXERCISE therapy ,VASCULAR endothelial growth factors ,LABORATORY mice ,ANIMAL disease models ,PHYSICAL mobility - Abstract
Background: Exercise might exert anti-tumoral effects in adult cancers but this question remains open in pediatric tumors, which frequently show a different biology compared to adult malignancies. We studied the effects of an exercise intervention on physical function, immune variables and tumoral response in a preclinical model of a highly aggressive pediatric cancer, high-risk neuroblastoma (HR-NB). Methods: 6-8-week-old male mice with orthotopically-induced HR-NB were assigned to a control (N=13) or exercise (5-week combined [aerobic+resistance]) group (N=17). Outcomes included physical function (cardiorespiratory fitness [CRF] and muscle strength), as well as related muscle molecular indicators, blood and tumor immune cell and molecular variables, tumor progression, clinical severity, and survival. Results: Exercise attenuated CRF decline (p=0.029 for the group-by-time interaction effect), which was accompanied by higher muscle levels of oxidative capacity (citrate synthase and respiratory chain complexes III, IV and V) and an indicator of antioxidant defense (glutathione reductase) in the intervention arm (all p=0.001), as well as by higher levels of apoptosis (caspase-3, p=0.029) and angiogenesis (vascular endothelial growth factor receptor-2, p=0.012). The proportion of 'hot-like' (i.e., with viable immune infiltrates in flow cytometry analyses) tumors tended to be higher (p=0.0789) in the exercise group (76.9%, vs. 33.3% in control mice). Exercise also promoted greater total immune (p=0.045) and myeloid cell (p=0.049) infiltration within the 'hot' tumors, with a higher proportion of two myeloid cell subsets (CD11C+ [dendritic] cells [p=0.049] and M2-like tumor-associated macrophages [p=0.028]), yet with no significant changes in lymphoid infiltrates or in circulating immune cells or chemokines/cytokines. No training effect was found either for muscle strength or anabolic status, cancer progression (tumor weight and metastasis, tumor microenvironment), clinical severity, or survival. Conclusions: Combined exercise appears as an effective strategy for attenuating physical function decline in a mouse model of HR-NB, also exerting some potential immune benefits within the tumor, which seem overall different from those previously reported in adult cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
3. ¿Es realmente necesario asociar una técnica antirreflujo a la gastrostomía de forma rutinaria? Experiencia en nuestro centro.
- Author
-
Guillén Redondo, P., Espinosa Góngora, R., Luis Huertas, A. L., Garcés Visier, C., Ramos Rodríguez, P., De La Puente Pérez, S., Souto Romero, H., Espinoza Vega, M., Rico Espiñeira, C., Riñón Pastor, C., and Alonso Calderón, J. L.
- Published
- 2021
4. Routine anti-reflux surgery combined with gastrostomy in children: is it really necessary? Our single-center experience.
- Author
-
Guillén Redondo, P., Espinosa Góngora, R., Luis Huertas, A. L., Garcés Visier, C., Ramos Rodríguez, P., De La Puente Pérez, S., Souto Romero, H., Espinoza Vega, M., Rico Espiñeira, C., Riñón Pastor, C., and Alonso Calderón, J. L.
- Subjects
GASTROSTOMY ,DEMOGRAPHIC surveys ,GASTROESOPHAGEAL reflux ,THERAPEUTICS ,CLINICAL trials - Abstract
Copyright of Cirugía Pediátrica (English Edition) is the property of Sociedad Espanola de Cirurgia Pediatrica and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
5. Pediatric perianal Crohn's disease behavior in the era of biologic therapy.
- Author
-
De La Puente S, Espinosa Góngora R, Souto Romero H, Rico Espiñeira C, Luis Huertas AL, Garcés Visier C, Ramos Rodríguez P, Muñoz Hernández D, Espinoza Vega ML, Acedo Ruiz JA, Maruszewski P, Riñón C, Morató Robert P, Palomino L, Velasco M, Martín Vega A, and Alonso Calderón JL
- Subjects
- Humans, Male, Child, Female, Retrospective Studies, Treatment Outcome, Biological Therapy, Crohn Disease drug therapy, Crohn Disease complications, Rectal Fistula therapy, Rectal Fistula complications
- Abstract
Aim of the Study: To describe perianal Crohn's disease behavior and the role of biological therapy in a sample of pediatric patients., Methods: A retrospective study of pediatric patients with Crohn's disease (CD) treated in our institution from 2017 to 2021, with a minimum follow up period of 6 months, was conducted. Patients were divided whether they had perianal disease (PD) or not. Baseline characteristics, extension of disease, growth failure rate, aggressive pattern rate, use of biological therapy and need for surgery, among other variables, were compared between both groups. Clinical and/or radiological improvement in the last 6 months of follow up was considered good control of PD., Results: Seventy eight pediatric patients with CD were included. Median age at diagnosis was 10.5 years, and median follow up time was 3.8 years. 64.1% patients were male. Of all, 15 (19.2%) had perianal disease, of which 10 had fistulizing findings and 5 had non fistulizing findings. PD was presented at diagnosis in 8 patients, and the rest developed it in a median time of 1 year from diagnosis. PD was associated with growth failure (p = 0.003), use of biological therapies (p = 0.005), and need for second line of biologics (p = 0.005). Most patients (12/15, 80%) had good control of PD with the treatment received., Conclusions: CD patients with PD seem to need a more aggressive treatment, with biological therapies playing a key role for its handling nowadays. These patients require close nutritional evaluation that ensures proper development and growth.
- Published
- 2023
- Full Text
- View/download PDF
6. Routine anti-reflux surgery combined with gastrostomy in children: is it really necessary? Our single-center experience.
- Author
-
Guillén Redondo P, Espinosa Góngora R, Luis Huertas AL, Garcés Visier C, Ramos Rodríguez P, De La Puente Pérez S, Souto Romero H, Espinoza Vega M, Rico Espiñeira C, Riñón Pastor C, and Alonso Calderón JL
- Subjects
- Child, Child, Preschool, Fundoplication, Humans, Infant, Postoperative Complications epidemiology, Retrospective Studies, Gastroesophageal Reflux epidemiology, Gastroesophageal Reflux surgery, Gastrostomy
- Abstract
Objective: To study gastroesophageal reflux (GER) in children undergoing gastrostomy in a single pediatric institution., Material and Methods: A retrospective study of patients undergoing gastrostomy from 2000 to 2017 was carried out. Demographic data, clinical data, progression, and complications were recorded. GER was considered positive in patients with clinical signs requiring antisecretory treatment, prokinetic treatment, or anti-reflux surgery to control symptoms., Results: 207 patients with a median age of 2 years [R: 0.25-18] were included. Neurological impairment was the most frequent underlying condition (74%). Swallowing difficulty and undernourishment were the main surgical indications for gastrostomy. Prior to gastrostomy, 96 out of 207 patients (46%) showed GER symptoms. Combined fundoplication and gastrostomy was performed in 41 (43%) patients with preexisting GER, 6 of whom showed GER worsening (4 required redo fundoplication). 5 complications following fundoplication were noted - gastric perforation, sustained Dumping syndrome, and gastroesophageal stenosis. 55 out of 96 (57%) patients with preexisting GER underwent gastrostomy alone. Clinical signs disappeared in 16 of them (29%) and improved or stabilized in 19 (35%). GER worsening occurred in 20 patients (36%), with subsequent fundoplication being required in 10 cases. In patients with no previous clinical signs (111 out of 207), GER symptoms occurred following gastrostomy in just 18 cases (16%), and only 2 patients required fundoplication., Conclusions: In our experience, routine anti-reflux surgery combined with gastrostomy is not justified. Individualized fundoplication should be considered in case of medical treatment failure. Further studies with an adequate design are required to establish which patients could really benefit from this procedure.
- Published
- 2021
7. Peripheral blood tumor-infiltrating lymphocytes in a neuroblastoma model.
- Author
-
Espinoza Vega ML, Luis Huertas AL, González Murillo A, Franco-Luzón L, and Ramírez Orellana M
- Subjects
- Animals, CD4-Positive T-Lymphocytes, Disease Models, Animal, Immunocompetence, Immunophenotyping, Immunotherapy, Mice, Mice, Inbred NOD, Neuroblastoma immunology, Neuroblastoma therapy, Spleen cytology, Lymphocytes, Tumor-Infiltrating, Neuroblastoma blood
- Abstract
Objective: To detect tumor-infiltrating lymphocytes (TILs) in the peripheral blood (PB) of a preclinical neuroblastoma model., Materials and Methods: Two types of preclinical models - immunodeficient mice and immunocompetent mice - were generated by injecting a cell suspension of neuroblastoma cell line NB36769 with MYCN gene (TH-MYCN+) overexpression. Spleen, tumor, and peripheral blood were studied using flow cytometry to detect PD-1+ T-cells. TCR-β immunosequencing was performed in matched samples (tumor and peripheral blood)., Results: Most PB T-cells of immunodeficient mice were CD4 (control: 83.1%; tumor: 86.1%), with a small proportion of PD-1+ T-cells (control: 0.4%; tumor: 0.3%). However, the percentage of PD-1+ T-cells in the spleen was higher (control: 6.5%; tumor: 6.2%), and it was expressed in the CD4+ subset only. Regarding the TCR repertoire of immunocompetent mice, the proportion of the 10 most frequent sequences was significantly higher in tumors (11.09% ± 2.83%) than in the peripheral blood (1.59% ± 0.59%) (p=0.024). These findings are suggestive of clonotype enrichment within the tumor. 9 out of the 10 most frequent tumor clones were identified in the matched peripheral blood sample in 2 mice, and 6 out of 10 in one mouse. In addition, TILs with shared sequences from different animals were found., Conclusions: Our results in terms of immunophenotype and clonality suggest the presence of PB T-cells which could include TILs in a preclinical neuroblastoma model.
- Published
- 2020
8. [Recurrence of uncomplicated intestinal intussusception. Can it be treated as an outpatient?]
- Author
-
Espinoza Vega ML, Martín Rivada A, Rico Espiñeira C, De Lucio Rodríguez M, Guillén Redondo P, Luis Huertas AL, Souto Romero H, Espinosa Góngora R, and Ollero Fresno JC
- Subjects
- Child, Child, Preschool, Enema methods, Female, Hospitalization economics, Humans, Infant, Length of Stay, Male, Recurrence, Retrospective Studies, Time Factors, Treatment Outcome, Ambulatory Care methods, Hospitalization statistics & numerical data, Intussusception therapy
- Abstract
Objectives: To estimate the recurrence rate of intussusception after successful enema reduction and to analyze the costs of hospital admission with the current management of this pathology., Material and Methods: A retrospective study over 5 years of 97 patients with confirmed diagnosis of intussusception was undertaken. Medical records were evaluated for patient demographic, clinical and radiological data. Patients with enema-reduced intussusception were selected and data respecting to timing and outcome of recurrences, and length of stay were analyzed. Recurrence was defined as a new episode of intussusception within 72 hours of the initial presentation. Costs were calculated using hospital-specific data., Results: During the study period there were 81/97 children with successful enema reduction. Mean length of stay was 35 hours in the conservative treatment group. There were 8 episodes of recurrence, 5 of them within the first 24 hours (6.17%), for an overall recurrence rate of 9.88%. 7 children were treated by repeated enema and only one patient needed surgery for persistent illness. Assuming the overall recurrence rate of 9.88%, it would require hospitalizing 16 patients to identify a single recurrence with a cost of 1,723.75 € per patient., Conclusions: Given the low recurrence rate for enema-reduced intussusception and the possibility of repeated enema for their treatment in most of recurrences, we strongly advocated for the outpatient management as a safe and cost-effective alternative.
- Published
- 2017
9. [Serious gastrointestinal complications after ingestion of a magnetic toy].
- Author
-
Flores Pérez P, Luis Huertas AL, Villalobos Pinto E, Pérez Martín MA, Souto Romero H, and de Mingo Micena L
- Subjects
- Child, Preschool, Female, Humans, Magnetic Phenomena, Magnetics, Severity of Illness Index, Foreign Bodies complications, Gastrointestinal Diseases etiology, Jejunum, Play and Playthings
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.